All Stories

  1. On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis

    Article • Gastroenterology Research and Practice, August 2018, Hindawi Publishing Corporation

    Dr. Muhammad Ali Khan, Dr Colin W. Howden

  2. Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast

    Article • Hepatology, November 2016, Wiley

    Dr Colin W. Howden

  3. Letter: possible association between PPI use and spontaneous bacterial peritonitis

    Article • Alimentary Pharmacology & Therapeutics, August 2015, Wiley

    Dr Colin W. Howden

  4. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study

    Article • Gastroenterology, August 2015, Elsevier

    Dr Colin W. Howden

  5. Tu1429 Is Proton Pump Inhibitor Use Associated With Delayed Gastric Emptying in Functional Dyspepsia Subjects?

    Article • Gastroenterology, April 2015, Elsevier

    Dr Colin W. Howden

  6. Tu1430 Functional Dyspepsia Treatment Trial (FDTT): Effect of Antidepressants on Mood Response in Functional Dyspepsia

    Article • Gastroenterology, April 2015, Elsevier

    Dr Colin W. Howden

  7. 199 Gastric Physiology Test Correlations in Functional Dyspepsia

    Article • Gastroenterology, April 2015, Elsevier

    Dr Colin W. Howden

  8. Tu1435 Functional Dyspepsia Treatment Trial (FDTT): Association of Adequate Relief Response and Psychological Measures

    Article • Gastroenterology, April 2015, Elsevier

    Dr Colin W. Howden

  9. Update on the Diagnosis and Management of Helicobacter pylori Infection in Adults

    Article • Journal of Clinical Gastroenterology, March 2015, Wolters Kluwer Health

    Dr Colin W. Howden

  10. Letter: PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin

    Article • Alimentary Pharmacology & Therapeutics, November 2014, Wiley

    Dr Colin W. Howden

  11. Economic Evaluations of Gastroesophageal Reflux Disease Medical Management

    Article • PharmacoEconomics, May 2014, Springer Science + Business Media

    Dr Colin W. Howden

  12. Tu1845 In Functional Dyspepsia, Are Meal-Related Symptoms Linked to Less Drinking Capacity?

    Article • Gastroenterology, May 2014, Elsevier

    Dr Colin W. Howden

  13. 1017 The Functional Dyspepsia Treatment Trial (FDTT): 5-HTT LPR and Gn β3 825C>T Are Not Pharmacogenetic Markers for FD Antidepressant Treatment Response

    Article • Gastroenterology, May 2014, Elsevier

    Dr Colin W. Howden

  14. 1016 GI Bowel Symptom Comorbidity in Functional Dyspepsia

    Article • Gastroenterology, May 2014, Elsevier

    Dr Colin W. Howden

  15. Response to Nahon et al. and Marmo et al.

    Article • The American Journal of Gastroenterology, September 2013, Wolters Kluwer Health

    Dr Colin W. Howden

  16. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding

    Article • Cochrane Database of Systematic Reviews, June 2013, Wiley

    Dr Colin W. Howden, Dr Gabriel Rada

  17. Commentary: improving the use of gastroprotective agents among high-risk NSAID users

    Article • Alimentary Pharmacology & Therapeutics, April 2013, Wiley

    Dr Colin W. Howden

  18. Response of Chronic Cough to Acid-Suppressive Therapy in Patients With Gastroesophageal Reflux Disease

    Article • CHEST Journal, March 2013, Elsevier

    Dr Colin W. Howden

  19. Effect of Comorbidity on Mortality in Patients With Peptic Ulcer Bleeding: Systematic Review and Meta-Analysis

    Article • The American Journal of Gastroenterology, February 2013, Wolters Kluwer Health

    Dr Colin W. Howden

  20. High-dose versus low-dose intravenous proton pump inhibitor treatment for bleeding peptic ulcers

    Article • Expert Review of Gastroenterology & Hepatology, December 2012, Taylor & Francis

    Dr Colin W. Howden

  21. Commentary: the link between community-acquired pneumonia and PPI use

    Article • Alimentary Pharmacology & Therapeutics, November 2012, Wiley

    Dr Colin W. Howden

  22. Commentary: PPIs and risk of serious infection in decompensated cirrhosis

    Article • Alimentary Pharmacology & Therapeutics, November 2012, Wiley

    Dr Colin W. Howden

  23. Major Complications of Pneumatic Dilation and Heller Myotomy for Achalasia: Single-Center Experience and Systematic Review of the Literature

    Article • The American Journal of Gastroenterology, October 2012, Wolters Kluwer Health

    Dr Colin W. Howden

  24. A rationale for multidisciplinary care in treating neuroendocrine tumours

    Article • Current Opinion in Endocrinology Diabetes and Obesity, August 2012, Wolters Kluwer Health

    Dr Colin W. Howden

  25. Commentary: something new to consider in the treatment of Helicobacter pylori infection?

    Article • Alimentary Pharmacology & Therapeutics, July 2012, Wiley

    Dr Colin W. Howden

  26. Concomitant Symptoms Itemized in the Reflux Disease Questionnaire Are Associated With Attenuated Heartburn Response to Acid Suppression

    Article • The American Journal of Gastroenterology, July 2012, Wolters Kluwer Health

    Dr Colin W. Howden

  27. Editorial: How Much Do PPIs Contribute to C. difficile Infections?

    Article • The American Journal of Gastroenterology, July 2012, Wolters Kluwer Health

    Dr Colin W. Howden, Dr Mark Miller

  28. Regurgitation Is Less Responsive to Acid Suppression Than Heartburn in Patients With Gastroesophageal Reflux Disease

    Article • Clinical Gastroenterology and Hepatology, June 2012, Elsevier

    Dr Colin W. Howden

  29. Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics

    Article • Contemporary Clinical Trials, May 2012, Elsevier

    Dr Colin W. Howden

  30. Recent Safety Concerns With Proton Pump Inhibitors

    Article • Journal of Clinical Gastroenterology, February 2012, Wolters Kluwer Health

    Dr Colin W. Howden

  31. Problem-Based Approach to Gastroenterology and Hepatology

    Article • January 2012, Wiley

    Dr Colin W. Howden

  32. PPI co-therapy did not adversely affect outcomes in clopidogrel users

    Article • Alimentary Pharmacology & Therapeutics, December 2011, Wiley

    Dr Colin W. Howden

  33. Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleeding

    Article • Cochrane Database of Systematic Reviews, October 2011, Wiley

    Dr Colin W. Howden

  34. The Interaction Between Proton Pump Inhibitors and Clopidogrel and Upper Gastrointestinal Bleeding

    Article • Gastrointestinal Endoscopy Clinics of North America, October 2011, Elsevier

    Dr Colin W. Howden

  35. Response of Regurgitation to Proton Pump Inhibitor Therapy in Clinical Trials of Gastroesophageal Reflux Disease

    Article • The American Journal of Gastroenterology, May 2011, Wolters Kluwer Health

    Dr Colin W. Howden

  36. Withdrawing PPI Treatment

    Article • The American Journal of Gastroenterology, February 2011, Wolters Kluwer Health

    Dr Colin W. Howden

  37. Systematic Review of the Epidemiology of Complicated Peptic Ulcer Disease: Incidence, Recurrence, Risk Factors and Mortality

    Article • Digestion, January 2011, Karger Publishers

    Dr Colin W. Howden

  38. Editorial: PPIs and Clopidogrel: The Band Plays On............

    Article • The American Journal of Gastroenterology, November 2010, Wolters Kluwer Health

    Dr Colin W. Howden

  39. The Safety of Drugs Used in Acid-related Disorders and Functional Gastrointestinal Disorders

    Article • Gastroenterology Clinics of North America, September 2010, Elsevier

    Dr Colin W. Howden

  40. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding

    Article • Cochrane Database of Systematic Reviews, July 2010, Wiley

    Dr Colin W. Howden

  41. Editorial: Just How “Difficult” Is It to Withdraw PPI Treatment?

    Article • The American Journal of Gastroenterology, July 2010, Wolters Kluwer Health

    Dr Colin W. Howden

  42. Proton pump inhibitor treatment for acute peptic ulcer bleeding

    Article • Cochrane Database of Systematic Reviews, May 2010, Wiley

    Dr Colin W. Howden

  43. Long-Term Tegaserod Treatment for Dysmotility-like Functional Dyspepsia: Results of Two Identical 1-year Cohort Studies

    Article • Digestive Diseases and Sciences, December 2009, Springer Science + Business Media

    Dr Colin W. Howden

  44. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding

    Article • October 2009, Wiley

    Dr Colin W. Howden

  45. Resident Physicianʼs Knowledge of Risk Factors for Upper Gastrointestinal Complications From NSAIDs

    Article • American Journal of Therapeutics, September 2009, Wolters Kluwer Health

    Dr Colin W. Howden

  46. The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Bleeding

    Article • Gastroenterology Clinics of North America, June 2009, Elsevier

    Dr Colin W. Howden

  47. T1942 Proton Pump Inhibitor (PPI) Treatment for Peptic Ulcer (PU) Bleeding: An Updated Cochrane Meta-Analysis of Randomized Controlled Trials (RCTs)

    Article • Gastroenterology, May 2009, Elsevier

    Dr Colin W. Howden

  48. 63 Proton Pump Inhibitor (PPI) Use Is Independently Associated with Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics with Ascites

    Article • Gastroenterology, May 2009, Elsevier

    Dr Colin W. Howden

  49. 229 Does Proton Pump Inhibitor (PPI) Treatment Initiated Before Endoscopy Work in Unselected Upper Gastrointestinal Bleeding? A Cochrane Systematic Review Update

    Article • Gastroenterology, May 2009, Elsevier

    Dr Colin W. Howden

  50. T1066 Proton Pump Inhibitor Compliance Does Not Impact GERD Symptom Resolution

    Article • Gastroenterology, May 2009, Elsevier

    Dr Colin W. Howden

  51. Control of 24-hour Intragastric Acidity With Morning Dosing of Immediate-release and Delayed-release Proton Pump Inhibitors in Patients With GERD

    Article • Journal of Clinical Gastroenterology, April 2009, Wolters Kluwer Health

    Dr Colin W. Howden

  52. Is There a Dark Side to Long-term Proton Pump Inhibitor Therapy?

    Article • American Journal of Therapeutics, November 2008, Wolters Kluwer Health

    Dr Colin W. Howden

  53. Use of Gastroprotection in Patients Discharged From Hospital on Nonsteroidal Anti-inflammatory Drugs

    Article • American Journal of Therapeutics, September 2008, Wolters Kluwer Health

    Dr Colin W. Howden

  54. Potential adverse effects of proton pump inhibitors

    Article • Current Gastroenterology Reports, June 2008, Springer Science + Business Media

    Dr Colin W. Howden

  55. Lillian Mary Matheson

    Article • BMJ, May 2008, BMJ

    Dr Colin W. Howden

  56. Use of Physician Education and Computer Alert to Improve Targeted Use of Gastroprotection Among NSAID Users

    Article • The American Journal of Gastroenterology, May 2008, Wolters Kluwer Health

    Dr Colin W. Howden

  57. W1065 Knowledge of Risk Factors for NSAID-Related Upper GI Complications and Role of Gastroprotection Among Senior Resident Physicians

    Article • Gastroenterology, April 2008, Elsevier

    Dr Colin W. Howden

  58. 187 Systematic Review of the Epidemiology of Complicated Peptic Ulcer: Incidence, Recurrence, Risk Factors and Mortality

    Article • Gastroenterology, April 2008, Elsevier

    Dr Colin W. Howden

  59. S1074 Tak-390MR, a Proton Pump Inhibitor with a Novel Dual Delayed Release Formulation, Maintains Healing and Controls Heartburn in GERD Patients with Healed Erosive Esophagitis

    Article • Gastroenterology, April 2008, Elsevier

    Dr Colin W. Howden

  60. T1086 Providers Disagree About Risk of Adverse Events with PPIs, and Beliefs Predict Adherence with “Best Practices” in Dyspepsia Management

    Article • Gastroenterology, April 2008, Elsevier

    Dr Colin W. Howden

  61. M1040 Adherence to “Best Practices” in Dyspepsia Management: A National Vignette Survey of Internists, Nurse Practitioners, Community Gastroenterologists and Experts

    Article • Gastroenterology, April 2008, Elsevier

    Dr Colin W. Howden

  62. Proton Pump Inhibitor Therapy for Suspected GERD-Related Chronic Laryngitis: A Meta-Analysis of Randomized Controlled Trials

    Article • Clinical Otolaryngology, April 2008, Wiley

    Dr Colin W. Howden

  63. Pharmacologic treatment of peptic ulcer bleeding

    Article • Current Treatment Options in Gastroenterology, April 2007, Springer Science + Business Media

    Dr Colin W. Howden

  64. H2-ANTAGONISTS AND ALCOHOL

    Article • Alimentary Pharmacology & Therapeutics, March 2007, Wiley

    Dr Colin W. Howden

  65. Review: interactions between H2-antagonists and non-steroidal anti-inflammatory drugs

    Article • Alimentary Pharmacology & Therapeutics, March 2007, Wiley

    Dr Colin W. Howden

  66. The relationship between suppression of acidity and gastric ulcer healing rates

    Article • Alimentary Pharmacology & Therapeutics, March 2007, Wiley

    Dr Colin W. Howden

  67. Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled Trials

    Article • Mayo Clinic Proceedings, March 2007, Elsevier

    Dr Colin W. Howden

  68. Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled Trials

    Article • Mayo Clinic Proceedings, March 2007, Elsevier

    Dr Colin W. Howden

  69. On-Demand Therapy for Gastroesophageal Reflux Disease

    Article • The American Journal of Gastroenterology, March 2007, Wolters Kluwer Health

    Dr Colin W. Howden

  70. Proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding

    Article • Journal of Gastroenterology and Hepatology, November 2006, Wiley

    Dr Colin W. Howden

  71. Proton Pump Inhibitor Therapy for Suspected GERD-Related Chronic Laryngitis: A Meta-Analysis of Randomized Controlled Trials

    Article • The American Journal of Gastroenterology, November 2006, Wolters Kluwer Health

    Dr Colin W. Howden

  72. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding

    Article • October 2006, Wiley

    Dr Colin W. Howden

  73. To Establish the Efficacy of PPI Therapy for Ulcer Bleeding in the United States, Do We Need More Patients or More PPIs?

    Article • The American Journal of Gastroenterology, September 2006, Wolters Kluwer Health

    Dr Colin W. Howden

  74. Proton pump inhibitor treatment for acute peptic ulcer bleeding

    Article • January 2006, Wiley

    Dr Colin W. Howden

  75. Explaining Divergent Results of Meta-Analyses on Proton Pump Inhibitor Treatment for Ulcer Bleeding

    Article • Gastroenterology, November 2005, Elsevier

    Dr Colin W. Howden

  76. Primary-Care Physicians' Perceptions and Practices on the Management of GERD: Results of a National Survey

    Article • The American Journal of Gastroenterology, June 2005, Wolters Kluwer Health

    Dr Colin W. Howden

  77. Response to Monge and Montes

    Article • Journal of Clinical Gastroenterology, March 2005, Wolters Kluwer Health

    Dr Colin W. Howden

  78. Is no NSAID a good NSAID? approaches to NSAID-associated upper gastrointestinal disease

    Article • Current Gastroenterology Reports, December 2004, Springer Science + Business Media

    Dr Colin W. Howden

  79. Who???s Afraid of the Big Bad GERD?

    Article • Journal of Clinical Gastroenterology, October 2004, Wolters Kluwer Health

    Dr Colin W. Howden

  80. Management of acid-related disorders in patients with dysphagia

    Article • The American Journal of Medicine Supplements, September 2004, Elsevier

    Dr Colin W. Howden

  81. Hepatitis C Knowledge among Primary Care Residents: Is Our Teaching Adequate for the Times?

    Article • The American Journal of Gastroenterology, September 2004, Wolters Kluwer Health

    Dr Colin W. Howden

  82. Proton pump inhibitor treatment for acute peptic ulcer bleeding

    Article • July 2004, Wiley

    Dr Colin W. Howden

  83. H. Pylori and GERD: Is Less More?

    Article • The American Journal of Gastroenterology, July 2004, Wolters Kluwer Health

    Dr Colin W. Howden

  84. A National Survey of Primary Care Physicians??? Perceptions and Practices Related to Helicobacter pylori Infection

    Article • Journal of Clinical Gastroenterology, April 2004, Wolters Kluwer Health

    Dr Colin W. Howden

  85. Patient Anxiety and Elective Gastrointestinal Endoscopy

    Article • Journal of Clinical Gastroenterology, January 2004, Wolters Kluwer Health

    Dr Colin W. Howden

  86. Universal precautions guideline: self-reported compliance by gastroenterologists and gastrointestinal endoscopy nurses-a decade's lack of progress

    Article • The American Journal of Gastroenterology, November 2003, Wolters Kluwer Health

    Dr Colin W. Howden

  87. Proton pump inhibitors (PPI) in the treatment of peptic ulcer bleeding: a cochrane collaboration meta-analysis of randomized controlled trials (RCTS)

    Article • The American Journal of Gastroenterology, September 2003, Wolters Kluwer Health

    Dr Colin W. Howden

  88. Systematic review: Does the evidence support an association between cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH)?

    Article • Gastroenterology, April 2003, Elsevier

    Dr Colin W. Howden

  89. A Systematic Review of Alternative Therapies in the Irritable Bowel Syndrome

    Article • Archives of Internal Medicine, February 2003, American Medical Association (AMA)

    Dr Colin W. Howden

  90. Knowledge, Attitudes, and Practice Styles of North American Pediatric Gastroenterologists:Helicobacter pylori Infection

    Article • Journal of Pediatric Gastroenterology and Nutrition, February 2003, Wolters Kluwer Health

    Dr Colin W. Howden

  91. A ‘test-and-treat’ strategy is obsolete in primary care

    Article • January 2003, Springer Science + Business Media

    Dr Colin W. Howden

  92. Lansoprazole reduced recurrence of ulcer complications in long term use of low dose aspirin

    Article • Evidence-Based Medicine, January 2003, BMJ

    Dr Colin W. Howden

  93. Proton pump inhibitors for bleeding peptic ulcers

    Article • Cochrane Database of Systematic Reviews, July 2002, Wiley

    Dr Colin W. Howden

  94. Placement of a covered metal stent via gastrostomy for management of malignant duodenocolic fistula with duodenal obstruction

    Article • Gastrointestinal Endoscopy, June 2002, Elsevier

    Dr Colin W. Howden

  95. Current liver biopsy practices for suspected parenchymal liver diseases in the United States: the evolving role of radiologists

    Article • The American Journal of Gastroenterology, June 2002, Wolters Kluwer Health

    Dr Colin W. Howden

  96. Response to Dr. Longstreth

    Article • The American Journal of Gastroenterology, January 2002, Wolters Kluwer Health

    Dr Colin W. Howden

  97. Therapeutic Equivalence of Lansoprzole and Esomeprazole

    Article • Clinical Drug Investigation, January 2002, Springer Science + Business Media

    Dr Colin W. Howden

  98. Evidence for Therapeutic Equivalence of Lansoprazole 30mg and Esomeprazole 40mg in the Treatment of Erosive Oesophagitis

    Article • Clinical Drug Investigation, January 2002, Springer Science + Business Media

    Dr Colin W. Howden

  99. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease

    Article • Best Practice & Research Clinical Gastroenterology, June 2001, Elsevier

    Dr Colin W. Howden

  100. The utility of urgent colonoscopy in the evaluation of acute lower gastrointestinal tract bleeding: a 2-year experience from a single center

    Article • The American Journal of Gastroenterology, June 2001, Wolters Kluwer Health

    Dr Colin W. Howden

  101. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies

    Article • The American Journal of Gastroenterology, June 2001, Wolters Kluwer Health

    Dr Colin W. Howden

  102. Meta-analysis analysis of medical therapies for chronic anal fissure

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  103. H. pylori (Hp), intragastric (IG) pH and esophageal acid exposure (EAE) — The GERD triangle

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  104. Meta-analysis of randomized controlled trials comparing plastic and metal stents for palliation of malignant obstructive jaundice

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  105. Intravenous proton pump inhibitors (IV PPI) for peptic ulcer hemorrhage (PUH) meta-analysis of randomized controlled trials (RCTs) allowing endoscopic treatment (ET)

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  106. Nocturnal gastric acid secretion is not synonymous with nocturnal esophageal acid exposure except in the presence of hiatal hernia

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  107. Internet survey of practice patterns by pediatric gastroenterologists for the management of pediatric H. pylori (Hp) infection

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  108. An audit of the utility of in-patient fecal occult blood testing

    Article • The American Journal of Gastroenterology, April 2001, Wolters Kluwer Health

    Dr Colin W. Howden

  109. Cost savings following intervention with a “test-and-treat” strategy for H. pylori infection in veterans on chronic antisecretory therapy

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  110. High dose IV PPI is less costly than standard medical management for preventing acute recurrence of peptic ulcer hemorrhage (PUH) after endoscopic therapy (ET)—A cost-minimization analysis

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  111. Meta-analysis analysis of medical therapies for chronic anal fissure

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  112. H. pylori (Hp), intragastric (IG) pH and esophageal acid exposure (EAE) — The GERD triangle

    Article • Gastroenterology, April 2001, Elsevier

    Dr Colin W. Howden

  113. The Effect of Stimulant Laxatives and Polyethylene Glycol-electrolyte Lavage Solution for Colonoscopy Preparation on Serum Electrolytes and Hemodynamics

    Article • Journal of Clinical Gastroenterology, March 2001, Wolters Kluwer Health

    Dr Colin W. Howden

  114. Differing attitudes toward virtual and conventional colonoscopy for colorectal cancer screening: surveys among primary care physicians and potential patients

    Article • The American Journal of Gastroenterology, March 2001, Wolters Kluwer Health

    Dr Colin W. Howden

  115. Prophylactic Antibiotic Administration Reduces Sepsis and Mortality in Acute Necrotizing Pancreatitis: A Meta-Analysis

    Article • Pancreas, January 2001, Wolters Kluwer Health

    Dr Colin W. Howden

  116. H. PYLORI ERADICATION IN FUNCTIONAL DYSPEPSIA

    Article • Journal of Gastroenterology and Hepatology, December 2000, Wiley

    Dr Colin W. Howden

  117. Diagnostic yield of colonoscopy in patients with a positive fecaloccult blood test

    Article • Gastrointestinal Endoscopy, December 2000, Elsevier

    Dr Colin W. Howden

  118. Changes in colorectal cancer over a 15-year period in a single United States city

    Article • The American Journal of Gastroenterology, December 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  119. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test

    Article • The American Journal of Gastroenterology, December 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  120. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy

    Article • The American Journal of Gastroenterology, November 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  121. Treatment of Helicobacter pylori Infection

    Article • Journal of Clinical Gastroenterology, September 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  122. Internet-based survey of primary care (PC) residents' opinions and practices related to gastroesophageal reflux disease (GERD)

    Article • The American Journal of Gastroenterology, September 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  123. Do patients and primary care physicians (PCP) differ in their choice between virtual colonoscopy (VC) and conventional colonoscopy (CC)?

    Article • The American Journal of Gastroenterology, September 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  124. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance

    Article • The American Journal of Gastroenterology, August 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  125. A survey of internal medicine residents' knowledge about Helicobacter pylori infection

    Article • The American Journal of Gastroenterology, August 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  126. Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey

    Article • The American Journal of Gastroenterology, June 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  127. 3324 Antibiotic prophylaxis before percutaneous endoscopic gastrostomy prevents infection and is cost saving.

    Article • Gastrointestinal Endoscopy, April 2000, Elsevier

    Dr Colin W. Howden

  128. Why might patients choose “virtual colonoscopy” over conventional colonoscopy?

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  129. “Virtual” or conventional colonoscopy for colorectal cancer screening (CRCS): How might primary care physicians (PCP) advise their patients?

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  130. Trends in esophageal cancer (EC): A 12-year experience at a teaching institution in Arkansas

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  131. Comparison of the knowledge and practices of internal medicine (IM) trainees in greece and the us concerning H. pylori (HP) infection

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  132. Oral pharmacokinetics of lansoprazole (L) after single and multiple doses as intact capsule and as simplified lansoprazole suspension (SLS)

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  133. Absorption of omeprazole (Om) is significantly impaired when given as simplified omeprazole suspension (SOS)

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  134. Initial diagnostic test for acute rectal bleeding: Urgent colonoscopy revisited

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  135. The colorectal cancer screening (CRCS) practices of internal medicine (IM) trainees in greece and the US compared

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  136. A survey of primary care residents opinions and practices related to hepatitis C (HCV)

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  137. Misuse of in-patient fecal occult blood testing (FOBT): Results of an audit

    Article • Gastroenterology, April 2000, Elsevier

    Dr Colin W. Howden

  138. Motility-modifying agents and management of disorders of gastrointestinal motility

    Article • Gastroenterology, February 2000, Elsevier

    Dr Colin W. Howden

  139. Vitamin B12 Levels During Prolonged Treatment With Proton Pump Inhibitors

    Article • Journal of Clinical Gastroenterology, January 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  140. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration

    Article • The American Journal of Gastroenterology, January 2000, Wolters Kluwer Health

    Dr Colin W. Howden

  141. What causes Helicobacter pylori -negative non-NSAID-related ulcers?

    Article • January 2000, Springer Science + Business Media

    Dr Colin W. Howden

  142. Extragastric manifestations of Helicobacter pylori — are they relevant?

    Article • January 2000, Springer Science + Business Media

    Dr Colin W. Howden

  143. A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection

    Article • The American Journal of Gastroenterology, November 1999, Wolters Kluwer Health

    Dr Colin W. Howden

  144. Metaanalysis of randomized controlled trials of endoscopic retrograde cholangiography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis

    Article • The American Journal of Gastroenterology, November 1999, Wolters Kluwer Health

    Dr Colin W. Howden

  145. Simplified lansoprazole suspension- a liquid formulation of lansoprazole- effectively suppresses intragastric acidity when administered through a gastrostomy

    Article • The American Journal of Gastroenterology, July 1999, Wolters Kluwer Health

    Dr Colin W. Howden

  146. Non–Gastrointestinal Tract Associations of Helicobacter pylori Infection

    Article • Archives of Internal Medicine, May 1999, American Medical Association (AMA)

    Dr Colin W. Howden

  147. Guidelines for the management of Helicobacter pylori infection

    Article • The American Journal of Gastroenterology, December 1998, Wolters Kluwer Health

    Dr Colin W. Howden

  148. Treating Helicobacter pylori

    Article • Archives of Internal Medicine, November 1998, American Medical Association (AMA)

    Dr Colin W. Howden

  149. Acid-related disorders in the new millennium

    Article • European Journal of Gastroenterology & Hepatology, September 1998, Wolters Kluwer Health

    Dr Colin W. Howden

  150. Changing trends in esophageal cancer: a 15-year experience in a single center

    Article • The American Journal of Gastroenterology, May 1998, Wolters Kluwer Health

    Dr Colin W. Howden

  151. Changing demographics of gastric cancer: 15-year experience

    Article • Gastroenterology, April 1998, Elsevier

    Dr Colin W. Howden

  152. Long term effects of large volume paracentesis (LVP) on renal function

    Article • Gastroenterology, April 1998, Elsevier

    Dr Colin W. Howden

  153. Do primary care physicians (PCP) understand colorectal cancer screening (CRCS)? Results of a national survey

    Article • Gastroenterology, April 1998, Elsevier

    Dr Colin W. Howden

  154. Changing demographics of colorectal cancer (CRC): A 15-year experience

    Article • Gastroenterology, April 1998, Elsevier

    Dr Colin W. Howden

  155. A Study of the Prevalence of Helicobacter pylori Infection and Other Markers of Upper Gastrointestinal Tract Disease in Patients With Rosacea

    Article • The American Journal of Gastroenterology, February 1998, Wolters Kluwer Health

    Dr Colin W. Howden

  156. Prospective, randomized, controlled comparison of the use of polyethylene glycol electrolyte lavage solution in four-liter versus two-liter volumes and pretreatment with either magnesium citrate or bisacodyl for colonoscopy preparation

    Article • Gastrointestinal Endoscopy, February 1998, Elsevier

    Dr Colin W. Howden

  157. Gastrointestinal and Hepatic Manifestations of Hereditary Hemorrhagic Telangiectasia

    Article • Digestive Diseases, January 1998, Karger Publishers

    Dr Colin W. Howden

  158. For What Conditions is There Evidence-Based Justification for Treatment of Helicobacter pylori Infection?

    Article • Gastroenterology, December 1997, Elsevier

    Dr Colin W. Howden

  159. Randomized, controlled study of pretreatment with magnesium citrate on the quality of colonoscopy preparation with polyethylene glycol electrolyte lavage solution

    Article • Gastrointestinal Endoscopy, December 1997, Elsevier

    Dr Colin W. Howden

  160. Randomized controlled trial of rectal tube placement for the management of abdominal distension following colonoscopy

    Article • Gastrointestinal Endoscopy, November 1997, Elsevier

    Dr Colin W. Howden

  161. Lack of Evidence for an Association Between Heliobacter pylori Infection and the Anorexia of Aging

    Article • Archives of Internal Medicine, August 1997, American Medical Association (AMA)

    Dr Colin W. Howden

  162. Lack of evidence for an association between Helicobacter pylori infection and the anorexia of aging

    Article • Archives of Internal Medicine, August 1997, American Medical Association (AMA)

    Dr Colin W. Howden

  163. Malignant Transformation in a Duodenal Villous Adenoma of the Afferent Limb of Billroth II Anastomosis

    Article • Journal of Clinical Gastroenterology, June 1997, Wolters Kluwer Health

    Dr Colin W. Howden

  164. Helicobacter pylori: clarifying the issues and curing the disease

    Article • European Journal of Gastroenterology & Hepatology, April 1997, Wolters Kluwer Health

    Dr Colin W. Howden

  165. Recurrent Peptic Ulceration

    Article • Digestive Diseases, January 1997, Karger Publishers

    Dr Colin W. Howden

  166. Clinical Expressions of Helicobacter pylori Infection

    Article • The American Journal of Medicine, May 1996, Elsevier

    Dr Colin W. Howden

  167. Is ?Second look? endoscopy necessary after peg?

    Article • Gastrointestinal Endoscopy, April 1996, Elsevier

    Dr Colin W. Howden

  168. How many patients must we treat for Helicobacter pylori infection to prevent a recurrent duodenal ulcer hemorrhage?

    Article • Gastrointestinal Endoscopy, February 1996, Elsevier

    Dr Colin W. Howden

  169. The Rationale for Continuous Maintenance Treatment of Reflux Esophagitis

    Article • Archives of Internal Medicine, July 1995, American Medical Association (AMA)

    Dr Colin W. Howden

  170. The rationale for continuous maintenance treatment of reflux esophagitis

    Article • Archives of Internal Medicine, July 1995, American Medical Association (AMA)

    Dr Colin W. Howden

  171. The risk of colon neoplasms in Barrett's esophagus: A re-analysis of nine controlled trials

    Article • Gastroenterology, April 1995, Elsevier

    Dr Colin W. Howden

  172. Optimizing acid suppression for treatment of acid-related diseases

    Article • Digestive Diseases and Sciences, February 1995, Springer Science + Business Media

    Dr Colin W. Howden

  173. Appropriate acid suppression in the treatment of acid-related conditions

    Article • Pharmacology & Therapeutics, January 1994, Elsevier

    Dr Colin W. Howden

  174. Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding

    Article • Digestive Diseases and Sciences, September 1993, Springer Science + Business Media

    Dr Colin W. Howden

  175. Advances in the therapeutic uses of histamine H2-receptor antagonists

    Article • Bailliére&#x027 s Clinical Gastroenterology, March 1993, Elsevier

    Dr Colin W. Howden

  176. Prevalence of esophagitis

    Article • Digestive Diseases and Sciences, September 1992, Springer Science + Business Media

    Dr Colin W. Howden

  177. Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux Disease

    Article • Digestion, January 1992, Karger Publishers

    Dr Colin W. Howden

  178. Further Evidence for an Interaction between Alcohol and Certain H2-Receptor Antagonists

    Article • Alcoholism Clinical and Experimental Research, November 1991, Wiley

    Dr Colin W. Howden

  179. Omeprazole

    Article • BMJ, October 1991, BMJ

    Dr Colin W. Howden

  180. Drug name confusion

    Article • The Lancet, July 1991, Elsevier

    Dr Colin W. Howden

  181. Antisecretory therapy and genotoxicity

    Article • Digestive Diseases and Sciences, May 1991, Springer Science + Business Media

    Dr Colin W. Howden

  182. Omeprazole

    Article • Digestive Diseases and Sciences, April 1991, Springer Science + Business Media

    Dr Colin W. Howden

  183. Clinical Pharmacology of Omeprazole

    Article • Clinical Pharmacokinetics, January 1991, Springer Science + Business Media

    Dr Colin W. Howden

  184. Development of a New Gastric Antisecretory Drug for Clinical Use

    Article • January 1991, Springer Science + Business Media

    Dr Colin W. Howden

  185. Medical treatment of peptic ulcer

    Article • Current Opinion in Gastroenterology, December 1990, Wolters Kluwer Health

    Dr Colin W. Howden

  186. Miscellaneous matters relating to the stomach and duodenum

    Article • Current Opinion in Gastroenterology, December 1990, Wolters Kluwer Health

    Dr Colin W. Howden

  187. New drugs in the treatment of gastroduodenal disorders

    Article • Current Opinion in Gastroenterology, December 1989, Wolters Kluwer Health

    Dr Colin W. Howden

  188. Drug metabolism in liver disease

    Article • Pharmacology & Therapeutics, January 1989, Elsevier

    Dr Colin W. Howden

  189. Simple analgesics in pregnancy:: Author's reply

    Article • BMJ, January 1987, BMJ

    Dr Colin W. Howden

  190. Relationship between gastric secretion and infection.

    Article • Gut, January 1987, BMJ

    Dr Colin W. Howden

  191. Treatment of common minor ailments.

    Article • BMJ, December 1986, BMJ

    Dr Colin W. Howden

  192. Relapse of duodenal ulcer

    Article • BMJ, December 1986, BMJ

    Dr Colin W. Howden

  193. RIOPROSTIL AND DUODENAL ULCER

    Article • The Lancet, September 1986, Elsevier

    Dr Colin W. Howden

  194. Enprostil and ranitidine in duodenal ulcer healing.

    Article • BMJ, June 1986, BMJ

    Dr Colin W. Howden

  195. Effect of Ketoconazole on the Synthesis of Cortisol

    Article • The Journal of Infectious Diseases, February 1986, Oxford University Press (OUP)

    Dr Colin W. Howden

  196. Spontaneous Hypochlorhydria in Man: Possible Causes and Consequences

    Article • Digestive Diseases, January 1986, Karger Publishers

    Dr Colin W. Howden

  197. Gastric secretion in patients with typhoid.

    Article • Gut, December 1985, BMJ

    Dr Colin W. Howden

  198. Comparison of different strategies for treating duodenal ulcer

    Article • BMJ, June 1985, BMJ

    Dr Colin W. Howden

  199. NOCTURNAL DOSES OF H2 RECEPTOR ANTAGONISTS FOR DUODENAL ULCER

    Article • The Lancet, March 1985, Elsevier

    Dr Colin W. Howden

  200. Pharmacodynamic Studies in Normal Volunteers with MDL-899, a New Arteriolar Vasodilator

    Article • Journal of Cardiovascular Pharmacology, July 1983, Wolters Kluwer Health

    Dr Colin W. Howden

  201. TOXOPLASMA ENCEPHALITIS

    Article • The Lancet, June 1983, Elsevier

    Dr Colin W. Howden

  202. Idiopathic hypoparathyroidism associated with stable untreated myelofibrosis.

    Article • BMJ, April 1983, BMJ

    Dr Colin W. Howden

  203. Pharmacodynamic Studies with a Specific α2-Adrenoceptor Agonist (BHT-933) in Man

    Article • Journal of Cardiovascular Pharmacology, July 1982, Wolters Kluwer Health

    Dr Colin W. Howden

  204. H. pylori-Related Diseases: Diagnosis and Treatment

    Article • Springer Science + Business Media

    Dr Colin W. Howden